Bayesian calendar-time survival analysis with epidemic curve priors and variant-specific infection hazards
Fuente:
arXiv
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Preprint |
| Veröffentlicht: |
2026
|
| Schlagworte: | |
| Online-Zugang: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1866908846269661184 |
|---|---|
| author | Dahl, Angela M Brown, Elizabeth R |
| author_facet | Dahl, Angela M Brown, Elizabeth R |
| contents | In this paper, we develop a Bayesian calendar-time survival model motivated by infectious disease prevention studies occurring during an epidemic, when the risk of infection can change rapidly as the epidemic curve shifts. For studies in which a biomarker is the predictor of interest, we include the option to estimate a threshold of protection for the biomarker. If the intervention is hypothesized to have different associations with several circulating viral variants, or if the infectiousness of the dominant variant(s) changes over the course of the study, we treat infection from different variants as competing risks. We also introduce a novel method for incorporating existing epidemic curve estimates into an informative prior for the baseline hazard function, enabling estimation of the intervention's association with infection risk during periods of calendar time with minimal follow-up in one or more comparator groups. We demonstrate the strengths of this method via simulations, and we apply it to data from an observational COVID-19 vaccine study. |
| format | Preprint |
| id |
arxiv_https___arxiv_org_abs_2602_18677 |
| institution | arXiv |
| publishDate | 2026 |
| record_format | arxiv |
| spellingShingle | Bayesian calendar-time survival analysis with epidemic curve priors and variant-specific infection hazards Dahl, Angela M Brown, Elizabeth R Methodology Applications In this paper, we develop a Bayesian calendar-time survival model motivated by infectious disease prevention studies occurring during an epidemic, when the risk of infection can change rapidly as the epidemic curve shifts. For studies in which a biomarker is the predictor of interest, we include the option to estimate a threshold of protection for the biomarker. If the intervention is hypothesized to have different associations with several circulating viral variants, or if the infectiousness of the dominant variant(s) changes over the course of the study, we treat infection from different variants as competing risks. We also introduce a novel method for incorporating existing epidemic curve estimates into an informative prior for the baseline hazard function, enabling estimation of the intervention's association with infection risk during periods of calendar time with minimal follow-up in one or more comparator groups. We demonstrate the strengths of this method via simulations, and we apply it to data from an observational COVID-19 vaccine study. |
| title | Bayesian calendar-time survival analysis with epidemic curve priors and variant-specific infection hazards |
| topic | Methodology Applications |
| url | https://arxiv.org/abs/2602.18677 |